Sensus Healthcare, Inc. (SRTS)
NASDAQ: SRTS · Real-Time Price · USD
4.710
-0.020 (-0.42%)
Apr 1, 2025, 10:33 AM EDT - Market open
Sensus Healthcare Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Sensus Healthcare stock have an average target of 13, with a low estimate of 12 and a high estimate of 14. The average target predicts an increase of 176.01% from the current stock price of 4.71.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Sensus Healthcare stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Maintains $18 → $13 | Strong Buy | Maintains | $18 → $13 | +176.01% | Mar 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $12 | Strong Buy | Maintains | $11 → $12 | +154.78% | Feb 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $11 | Strong Buy | Maintains | $10 → $11 | +133.55% | Nov 18, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $12 → $14 | Strong Buy | Maintains | $12 → $14 | +197.24% | Nov 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +112.31% | Aug 12, 2024 |
Financial Forecast
Revenue This Year
45.61M
from 41.81M
Increased by 9.09%
Revenue Next Year
55.78M
from 45.61M
Increased by 22.30%
EPS This Year
0.43
from 0.41
Increased by 4.63%
EPS Next Year
0.65
from 0.43
Increased by 51.32%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 50.8M | 64.2M | 70.2M | ||
| Avg | 45.6M | 55.8M | 64.1M | ||
| Low | 41.5M | 48.5M | 57.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 21.6% | 40.7% | 25.9% | ||
| Avg | 9.1% | 22.3% | 14.9% | ||
| Low | -0.8% | 6.3% | 3.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.58 | 1.01 | 0.92 | ||
| Avg | 0.43 | 0.65 | 0.58 | ||
| Low | 0.21 | 0.23 | 0.25 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 41.7% | 136.4% | 43.2% | ||
| Avg | 4.6% | 51.3% | -9.9% | ||
| Low | -49.5% | -47.1% | -60.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.